In DCIS, β-catenin expression is increased and conserved with IDC where Wnt/β-catenin is highly activated (117) and GSK3b protein expression is decreased in IDC tissues, suggesting accumulation of β-catenin (118). The gene discussed is GSK3B; the disease is ductal breast carcinoma in situ.